跳转至内容
Merck

SML1794

Sigma-Aldrich

替诺福韦二吡呋酯 富马酸酯

≥98% (HPLC)

别名:

Bis(POC)PMPA 富马酸酯, 双{[((异丙氧基羰基)氧基]甲基}({[((2R)-1-(6-氨基-9H-嘌呤-9-基)-2-丙烷基]氧基}甲基)膦酸酯 富马酸酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C19H30N5O10P · C4H4O4
分子量:
635.51
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

H2O: 3 mg/mL, clear (warmed)

儲存溫度

2-8°C

SMILES 字串

OC(/C=C/C(O)=O)=O.NC1=C2C(N(C[C@@H](C)OCP(OCOC(OC(C)C)=O)(OCOC(OC(C)C)=O)=O)C=N2)=NC=N1

InChI

1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1

InChI 密鑰

VCMJCVGFSROFHV-WZGZYPNHSA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

富马酸替诺福韦二吡呋酯(tenofovir disoproxil fumarate)是替诺福韦的前体药,一种可引起DNA转录提前终止的核苷酸类似物逆转录酶抑制剂(nRTI)。 在T细胞系和原代血淋巴细胞中,替诺福韦二吡呋酯的抗病毒活性是替诺福韦的100倍以上,原因就在于其快速的细胞内摄取。 富马酸替诺福韦酯已通过单独和多种联合给药用于预防和治疗艾滋病(HIV/AIDS)和慢性乙肝病毒感染,并列入世界卫生组织基本药物标准清单中。
富马酸替诺福韦酯是替诺福韦的一种前药,一种核苷酸类似物逆转录酶抑制剂(nRTI);抗逆转录病毒。
富马酸替诺福韦酯(替诺福韦DF)是一种对人类免疫缺陷病毒(HIV)-1、HIV-2和嗜肝病毒等逆转录病毒具有活性的核苷酸类似物。

象形圖

Health hazardExclamation mark

訊號詞

Warning

危險聲明

危險分類

Aquatic Chronic 3 - Eye Irrit. 2 - STOT RE 2

標靶器官

Bone,Kidney

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Tracy P Trang et al.
Expert opinion on drug safety, 15(9), 1287-1294 (2016-07-09)
Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) are nucleoside reverse transcriptase inhibitors approved as pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV). Prophylactic TDF-based regimens have been shown to reduce the risk of HIV infection by 74 to 92% among
Kevin R Robertson et al.
AIDS (London, England), 30(15), 2315-2321 (2016-06-23)
The objective was to determine whether maraviroc (MVC) has unique neurocognitive benefits in the context of initial antiretroviral therapy (ART). Randomized, double-blind, placebo-controlled, 48-week trial. Participants were enrolled in US AIDS Clinical Trials Group clinical trial sites. Total 262 ART-naive
Tenofovir Disoproxil Fumarate
Kearney B P, et al.
Clinical Pharmacokinetics, 43(9), 595-612 (2004)
B L Robbins et al.
Antimicrobial agents and chemotherapy, 42(3), 612-617 (1998-03-28)
Bis(isopropyloxymethylcarbonyl) 9-R-(2-phosphonomethoxypropyl)adenine [bis(POC)PMPA] has been identified as a novel prodrug of PMPA. The anti-human immunodeficiency virus activity of bis(POC)PMPA was >100-fold greater than that of PMPA in both an established T-cell line and primary peripheral blood lymphocytes. This improved efficacy
Elisa De Crignis et al.
eLife, 10 (2021-07-31)
The molecular events that drive hepatitis B virus (HBV)-mediated transformation and tumorigenesis have remained largely unclear, due to the absence of a relevant primary model system. Here we propose the use of human liver organoids as a platform for modeling

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门